Summary of the MHRA Good Distribution Practice Symposium 2023
Recommendation

8 September 2026
Basel, Switzerland
Specifics in the Distribution of Medicinal Products
Just recently, you could read about the Good Manufacturing and Distribution Practice Symposia 2023, organized by the Medicines and Healthcare products Regulatory Agency (MHRA) on 21 and 22 February 2023. The first day of the conference focused on regulatory developments in the area of Good Distribution Practice (GDP).
A summary of the GDP part was now published on the MHRA Inspectorate blog. The article dated 02 May 2023 was written by Manuela Krasteva. In the introduction, she states that "the event included a variety of topics with a special emphasis on updates on our regulatory position and the MHRA’s role as a sovereign regulator. The theme of the day was largely influenced by the changes following the UK’s departure from the EU."
The blog post goes on, giving a brief summary of the individual contributions. Among the topics presented were the environmental changes and their impact on GDP activities, as well as the role of the so-called Responsible Person (Import), RPi.
To read the full article, please see the MHRA Inspectorate blog "MHRA Good Distribution Practice Symposium 2023".
Related GMP News
14.07.2026USP Proposes to Revise the Definition of Controlled Room Temperature in Chapter <659>
14.07.2026GDP in Hong Kong: Authority Provides Additional Information
14.07.2026GDP Inspection Responses: MHRA’s Expectations for AI Use in GxP Replies
14.07.2026FDA Warning Letter to Amazon: Unapproved New Drugs Sold via Online Marketplace
18.06.2026GDPA Participated as an Observer in the EMA GMDP-IWG Interested Parties Meeting


